Monte Rosa Therapeutics had a revenue of 84.93M in the quarter ending Mar 31, 2025, with 40.04%. This bring the company's revenue in the last twelve months to 159.49M, Decreased 110.90%. In the fiscal year ending Dec 31, 2024, Monte Rosa Therapeutics had annual revenue of 75.62M with Infinity% growth.